Evidence map›Paper›PMID 34753507›Full record

ArticleJournal of experimental & clinical cancer research : CR2021

Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.

Tao Qin, Bai Li, Xiaoyue Feng, Shujun Fan, Lei Liu, Dandan Liu, Jun Mao, Ying Lu, Jinfeng Yang, Xiaotang Yu and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Tao QinDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Bai LiDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Xiaoyue FengDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Shujun FanDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Lei LiuDepartment of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Dandan LiuDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jun MaoDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Ying LuTeaching Laboratory of Morphology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jinfeng YangDepartment of Pathology, Xiangyang Central Hospital, Xiangyang, 441000, People's Republic of China.
Xiaotang YuDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Qingqing ZhangDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jun ZhangDepartment of Dean, Dalian Medical University, Dalian, 116044, People's Republic of China.
Bo SongDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Man LiDepartment of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, Liaoning Province, People's Republic of China. liman19890930@sina.com.
Lianhong LiDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China. lilianhong917@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34753507
PMCPMC8577016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.